Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles
Maciej SerdaInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, PolandRobert GaweckiSilesian Center for Education and Interdisciplinary Research, 75 Pulku Piechoty 1a, 41-500 Chorzow, PolandMateusz DulskiInstitute of Materials Science, University of Silesia in Katowice, 75 Pulku Piechoty, 1A, Chorzow, 41-500, PolandMieczysław SajewiczInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, PolandE. TalikA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandM. SzubkaA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandMaciej ZubkoInstitute of Materials Science, University of Silesia in Katowice, 75 Pulku Piechoty, 1A, Chorzow, 41-500, PolandKatarzyna MalarzA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandAnna Mrozek‐WilczkiewiczA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandRobert MusiołInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, Poland
2022en
ABI
Annotatsiya
The 5-aminolevulinic acid (5-ALA) prodrug is widely used in clinical applications, primarily for skin cancer treatments and to visualize brain tumors in neurosurgery.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba